🇺🇸 FDA

Intelligence · Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs · EMA approved · by data quality · Page 21 of 39

  1. temsirolimus

    TORISEL

    INTRAVENOUS FDA: approved · EMA: approved

    L01XE09

  2. thalidomide

    THALOMID Bristol-Myers Squibb Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L04AX02

  3. thyrotropin alfa

    THYROGEN Sanofi-aventis Healthcare Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved

    H01AB01

  4. tipranavir

    APTIVUS

    ORAL FDA: approved · EMA: approved

    J05AE09

  5. tirzepatide

    MOUNJARO

    SUBCUTANEOUS FDA: approved · EMA: approved · PMDA: approved

    A10BX16

  6. tocilizumab

    ACTEMRA Hoffmann-La Roche

    INJECTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L04AC07

  7. tofacitinib

    XELJANZ Pfizer Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L04AF01

  8. tofersen

    QALSODY

    INTRATHECAL FDA: approved · EMA: approved · PMDA: approved

    N07XX22

  9. tolcapone

    TASMAR

    ORAL FDA: approved · EMA: approved

    N04BX01

  10. tolvaptan

    JINARC Otsuka Beijing Research Institute

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    C03XA01

  11. tovorafenib

    OJEMDA

    ORAL FDA: approved · EMA: approved

    L01EC04

  12. trabectedin

    YONDELIS Lacuna Pharma Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01CX01

  13. tralokinumab

    ADTRALZA

    INJECTION FDA: approved · EMA: approved

    D11

  14. trametinib

    MEKINIST Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L01EE01

  15. trastuzumab

    HERZUMA Pfizer Australia Pty Ltd

    INTRAVENOUS FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01FD01

  16. travoprost

    TRAVATAN Novartis Pharmaceuticals

    OPHTHALMIC FDA: approved · EMA: approved · TGA: approved

    S01ED51

  17. treosulfan

    TRECONDI

    INTRAVENOUS FDA: approved · EMA: approved

    L01AB02

  18. trifluridine

    LONSURF

    OPHTHALMIC FDA: approved · EMA: approved

    L01BC59

  19. tucatinib

    TUKYSA

    ORAL FDA: approved · EMA: approved

    L01EH03

  20. umeclidinium bromide

    ANORO ELLIPTA (PREVIOUSLY ANORO)

    INHALATION FDA: approved · EMA: approved

    R03AL03

  21. upadacitinib

    RINVOQ AbbVie

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L04AA44

  22. ustekinumab

    STELARA Janssen-Cilag Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    L04AC05

  23. vandetanib

    ZACTIMA

    ORAL FDA: approved · EMA: approved

    L01XE

  24. vemurafenib

    ZELBORAF Hoffmann-La Roche

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L01EC01

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.